Similar efficacy and tolerability of raltegravir-based antiretroviral therapy in HIV-infected patients, irrespective of age group, burden of comorbidities and concomitant medicatio...

por Naumann, U, Moll, A, Schleehauf, D, Lutz, T, Schmidt, W, Jaeger, H, Funke, B, Witte, V
Publicado 2016

Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2%

por Naumann, U, Moll, A, Schleehauf, D, Lutz, KT, Schmidt, W, Jaeger, H, Funke, B, Witte, V
Publicado 2019

Clinical application of genotypic co-receptor tropism testing from viral RNA and proviral DNA: week 24 analysis of the Berlin maraviroc cohort

por Obermeier, MJ, Carganico, A, Dupke, S, Schranz, D, Cordes, C, Freiwald, M, Klausen, G, Köppe, S, Schuler, C, Mayr, C, Schleehauf, D, Berg, T, Krznaric, I, Baumgarten, A
Publicado 2010